Emery-Dreifuss muscular dystrophy.

Authors:
Heller SA; Shih R; Kalra R; Kang PB.

Journal:
Muscle Nerve

Publication Year: 2019

DOI:
10.1002/mus.26782

PMCID:
PMC7154529

PMID:
31840275

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Muscle Nerve

Abbreviation: Muscle Nerve

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Physiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Assessment timing and choice of outcome measure in determining treatment response in chronic inflam…
Rajabally YA; Ouaja R; Kasiborski F and 2 more (2022) - Transparency Score: 3/6
Association of diaphragm thickness and echogenicity with age, sex, and body mass index in healthy s…
van Doorn JLM; Wijntjes J; Saris CGJ and 3 more (2022) - Transparency Score: 2/6
Body composition and myokines in a cohort of patients with Becker muscular dystrophy.
Barp A; Carraro E; Goggi G and 8 more (2022) - Transparency Score: 3/6
Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal study.
Moore U; Fernandez-Torron R; Jacobs M and 28 more (2022) - Transparency Score: 3/6
Cerebrospinal fluid characteristics of patients treated with intrathecal nusinersen for spinal musc…
Orbach R; Sagi L; Sadot E and 4 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"12 CONFLICT OF INTEREST Scott A. Heller has no conflicts of interest to disclose. Peter B. Kang has served as a consultant for AveXis and ChromaDex. He has served on an advisory board for Sarepta Therapeutics. He has received honoraria from Wiley for serving as an associate editor for Muscle & Nerve and from Wolters Kluwer for contributing material to UpToDate."

Evidence found in paper:

"Funding information The authors are grateful for the support of EDMD International, Inc"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025